Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation.
Am J Hematol
; 95(10): 1135-1141, 2020 Oct.
Article
em En
| MEDLINE
| ID: mdl-32530520
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Am J Hematol
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Israel